Imatinib mesylate efficacy in 72 previously treated Philadelphia-positive chronic myeloid leukemia patients with and without additional chromosomal changes: single-center results

Milena Holzerová; Edgar Faber; Jitka Veselovská; Helena Urbánková; Jana Balcárková; Šárka Rožmanová; Jaroslava Voglová; Jan Mužík; Karel Chroust; Karel Indrák; Marie Jarošová

doi:10.1016/j.cancergencyto.2008.12.013

Imatinib mesylate efficacy in 72 previously treated Philadelphia-positive chronic myeloid leukemia patients with and without additional chromosomal changes: single-center results

Cancer Genetics and Cytogenetics ◽

10.1016/j.cancergencyto.2008.12.013 ◽

2009 ◽

Vol 191 (1) ◽

pp. 1-9 ◽

Cited By ~ 8

Author(s):

Milena Holzerová ◽

Edgar Faber ◽

Jitka Veselovská ◽

Helena Urbánková ◽

Jana Balcárková ◽

...

Keyword(s):

Chronic Myeloid Leukemia ◽

Imatinib Mesylate ◽

Myeloid Leukemia ◽

Single Center ◽

Previously Treated ◽

Chromosomal Changes

Download Full-text

Evaluation of the Safety of Imatinib Mesylate in 200 Iraqi Patients with Chronic Myeloid Leukemia in the Chronic Phase: Single-Center Study

Turkish Journal of Hematology ◽

10.4274/tjh.2012.0135 ◽

2013 ◽

Vol 30 (4) ◽

pp. 387-39393 ◽

Cited By ~ 3

Author(s):

Bassam Francis Matti ◽

Alaadin Sahham Naji ◽

Alaa Fadhil Alwan

Keyword(s):

Chronic Myeloid Leukemia ◽

Imatinib Mesylate ◽

Myeloid Leukemia ◽

Chronic Phase ◽

Single Center ◽

Single Center Study ◽

Center Study

Download Full-text

Response assessment of patients with chronic myeloid leukemia receiving imatinib mesylate (Glivec) therapy: experience from a single center in a developing country

Leukemia & Lymphoma ◽

10.3109/10428194.2010.507416 ◽

2010 ◽

Vol 51 (10) ◽

pp. 1850-1854 ◽

Cited By ~ 6

Author(s):

Kunjahari Medhi ◽

Vinod Raina ◽

Lalit Kumar ◽

Atul Sharma ◽

Sameer Bakhshi ◽

...

Keyword(s):

Chronic Myeloid Leukemia ◽

Imatinib Mesylate ◽

Developing Country ◽

Myeloid Leukemia ◽

Response Assessment ◽

Single Center

Download Full-text

Response to treatment with imatinib mesylate in previously treated chronic-phase chronic myeloid leukemia patients in a hospital in Brazil

Genetics and Molecular Research ◽

10.4238/vol10-3gmr1073 ◽

2011 ◽

Vol 10 (3) ◽

pp. 2038-2048 ◽

Cited By ~ 1

Author(s):

C.A.P. Silveira ◽

M.B. Daldegan ◽

I. Ferrari

Keyword(s):

Chronic Myeloid Leukemia ◽

Imatinib Mesylate ◽

Myeloid Leukemia ◽

Chronic Phase ◽

Response To Treatment ◽

Previously Treated

Download Full-text

Faculty Opinions recommendation of Favorable long-term follow-up results over 6 years for response, survival, and safety with imatinib mesylate therapy in chronic-phase chronic myeloid leukemia after failure of interferon-alpha treatment.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1105194.561388 ◽

2008 ◽

Author(s):

Michael Deininger ◽

Paul La Rosée

Keyword(s):

Chronic Myeloid Leukemia ◽

Imatinib Mesylate ◽

Interferon Alpha ◽

Myeloid Leukemia ◽

Chronic Phase ◽

Long Term Follow Up ◽

Interferon Alpha Treatment

Download Full-text

Long-term follow-up of late chronic phase chronic myeloid leukemia patients treated with imatinib after interferon failure: a single center experience

Leukemia & Lymphoma ◽

10.1080/10428194.2021.1901094 ◽

2021 ◽

pp. 1-6

Author(s):

Sara Pepe ◽

Emilia Scalzulli ◽

Gioia Colafigli ◽

Alessio Di Prima ◽

Marco Mancini ◽

...

Keyword(s):

Chronic Myeloid Leukemia ◽

Myeloid Leukemia ◽

Chronic Phase ◽

Single Center ◽

Single Center Experience ◽

Long Term Follow Up

Download Full-text

The safety and efficacy of dasatinib plus nivolumab in patients with previously treated chronic myeloid leukemia: results from a phase 1b dose-escalation study

Leukemia & Lymphoma ◽

10.1080/10428194.2021.1889536 ◽

2021 ◽

pp. 1-7

Author(s):

Joaquín Martínez-López ◽

Satu Mustjoki ◽

Kimmo Porkka ◽

Rebecca B. Klisovic ◽

Dominik Wolf ◽

...

Keyword(s):

Chronic Myeloid Leukemia ◽

Dose Escalation ◽

Myeloid Leukemia ◽

Dose Escalation Study ◽

Safety And Efficacy ◽

Previously Treated ◽

Phase 1B

Download Full-text

Long-term safety and efficacy of imatinib in pediatric patients with chronic myeloid leukemia: single-center experience from China

International Journal of Hematology ◽

10.1007/s12185-020-03042-1 ◽

2021 ◽

Author(s):

Yuli Cai ◽

Chao Liu ◽

Ye Guo ◽

Xiaojuan Chen ◽

Li Zhang ◽

...

Keyword(s):

Chronic Myeloid Leukemia ◽

Myeloid Leukemia ◽

Pediatric Patients ◽

Single Center ◽

Safety And Efficacy ◽

Single Center Experience

Download Full-text

First-line treatment with imatinib mesylate in patients with chronic phase chronic myeloid leukemia: experience of a public hospital in a developing country of South America

Leukemia & Lymphoma ◽

10.3109/10428194.2011.653641 ◽

2012 ◽

Vol 53 (7) ◽

pp. 1417-1419

Author(s):

Carlos Alberto Pinto da Silveira ◽

Iris Ferrari

Keyword(s):

Chronic Myeloid Leukemia ◽

South America ◽

Imatinib Mesylate ◽

Developing Country ◽

Myeloid Leukemia ◽

Public Hospital ◽

Chronic Phase ◽

Line Treatment ◽

First Line ◽

First Line Treatment

Download Full-text

PCN6 FACTORS INFLUENCING PHYSICIAN RECOMMENDATION FOR IMATINIB MESYLATE IN CHRONIC PHASE CHRONIC MYELOID LEUKEMIA (CML) PATIENTS

Value in Health ◽

10.1016/s1098-3015(10)62148-1 ◽

2004 ◽

Vol 7 (3) ◽

pp. 247

Author(s):

SS Iyer ◽

WR Doucette

Keyword(s):

Chronic Myeloid Leukemia ◽

Imatinib Mesylate ◽

Myeloid Leukemia ◽

Chronic Phase ◽

Physician Recommendation ◽

Factors Influencing

Download Full-text

Effects of imatinib mesylate on normal bone marrow cells from chronic myeloid leukemia patients in complete cytogenetic response

Leukemia Research ◽

10.1016/j.leukres.2008.07.014 ◽

2009 ◽

Vol 33 (1) ◽

pp. 170-173 ◽

Cited By ~ 2

Author(s):

Fermin M. Sanchez-Guijo ◽

Jesus M. Hernandez ◽

Eva Lumbreras ◽

Patricia Morais ◽

Carlos Santamaría ◽

...

Keyword(s):

Bone Marrow ◽

Chronic Myeloid Leukemia ◽

Imatinib Mesylate ◽

Myeloid Leukemia ◽

Bone Marrow Cells ◽

Cytogenetic Response ◽

Normal Bone Marrow ◽

Normal Bone ◽

Complete Cytogenetic Response ◽

Marrow Cells

Download Full-text